These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33968071)

  • 21. Plasmablast-like Phenotype Among Antigen-Experienced CXCR5-CD19
    Szelinski F; Stefanski AL; Schrezenmeier E; Rincon-Arevalo H; Wiedemann A; Reiter K; Ritter J; Lettau M; Dang VD; Fuchs S; Frei AP; Alexander T; Lino AC; Dörner T
    Arthritis Rheumatol; 2022 Sep; 74(9):1556-1568. PubMed ID: 35507291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE.
    De Groof A; Ducreux J; Aleva F; Long AJ; Ferster A; van der Ven A; van de Veerdonk F; Houssiau FA; Lauwerys BR
    Rheumatology (Oxford); 2020 Mar; 59(3):668-677. PubMed ID: 31504941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
    Xiong YS; Cheng Y; Lin QS; Wu AL; Yu J; Li C; Sun Y; Zhong RQ; Wu LJ
    Rheumatology (Oxford); 2014 Feb; 53(2):250-9. PubMed ID: 24196391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus.
    Vásquez A; Baena A; González LA; Restrepo M; Muñoz CH; Vanegas-García A; Ortiz-Reyes B; Abdoel N; Rojas M; García LF; Vásquez G
    Cell Signal; 2019 Jun; 58():9-19. PubMed ID: 30840855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.
    Jacobi AM; Huang W; Wang T; Freimuth W; Sanz I; Furie R; Mackay M; Aranow C; Diamond B; Davidson A
    Arthritis Rheum; 2010 Jan; 62(1):201-10. PubMed ID: 20039404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus.
    Daridon C; Blassfeld D; Reiter K; Mei HE; Giesecke C; Goldenberg DM; Hansen A; Hostmann A; Frölich D; Dörner T
    Arthritis Res Ther; 2010; 12(6):R204. PubMed ID: 21050432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity.
    Nakayama Y; Kosek J; Capone L; Hur EM; Schafer PH; Ringheim GE
    J Immunol; 2017 Oct; 199(7):2388-2407. PubMed ID: 28848067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levels.
    Lazarus MN; Turner-Stokes T; Chavele KM; Isenberg DA; Ehrenstein MR
    Rheumatology (Oxford); 2012 Jul; 51(7):1208-15. PubMed ID: 22337941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling.
    Giltiay NV; Shu GL; Shock A; Clark EA
    Arthritis Res Ther; 2017 May; 19(1):91. PubMed ID: 28506291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep Phenotyping of CD11c
    Rincon-Arevalo H; Wiedemann A; Stefanski AL; Lettau M; Szelinski F; Fuchs S; Frei AP; Steinberg M; Kam-Thong T; Hatje K; Keller B; Warnatz K; Radbruch A; Lino AC; Schrezenmeier E; Dörner T
    Front Immunol; 2021; 12():635615. PubMed ID: 33777025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus.
    Chang NH; Li TT; Kim JJ; Landolt-Marticorena C; Fortin PR; Gladman DD; Urowitz MB; Wither JE
    J Autoimmun; 2015 Apr; 58():100-10. PubMed ID: 25678471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.
    Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P
    Front Immunol; 2021; 12():633658. PubMed ID: 34012432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.
    Vendel AC; Calemine-Fenaux J; Izrael-Tomasevic A; Chauhan V; Arnott D; Eaton DL
    J Immunol; 2009 Feb; 182(3):1509-17. PubMed ID: 19155498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.
    Patiño-Trives AM; Pérez-Sánchez C; Pérez-Sánchez L; Luque-Tévar M; Ábalos-Aguilera MC; Alcaide-Ruggiero L; Arias-de la Rosa I; Román-Rodríguez C; Seguí P; Espinosa M; Font P; Barbarroja N; Escudero-Contreras A; Antonio González-Reyes J; Manuel Villalba J; Collantes-Estévez E; Aguirre-Zamorano MÁ; López-Pedrera C
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2417-2430. PubMed ID: 34320837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus.
    Zhu YY; Su Y; Li ZG; Zhang Y
    PLoS One; 2012; 7(8):e44131. PubMed ID: 22952899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signaling Lymphocytic Activation Molecule Family Member 1 Engagement Inhibits T Cell-B Cell Interaction and Diminishes Interleukin-6 Production and Plasmablast Differentiation in Systemic Lupus Erythematosus.
    Karampetsou MP; Comte D; Suárez-Fueyo A; Katsuyama E; Yoshida N; Kono M; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2019 Jan; 71(1):99-108. PubMed ID: 30058241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype.
    Berggren O; Hagberg N; Alexsson A; Weber G; Rönnblom L; Eloranta ML
    PLoS One; 2017; 12(8):e0183946. PubMed ID: 28846748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.